Madhunapantula SV - Search Results

1

Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells.

Harish V, Tewari D, Mohd S, Govindaiah P, Babu MR, Kumar R, Gulati M, Gowthamarajan K, Madhunapantula SV, Chellappan DK, Gupta G, Dua K, Dallavalasa S, Singh SK. Harish V, et al. Among authors: madhunapantula sv. Pharmaceutics. 2022 Nov 7;14(11):2403. doi: 10.3390/pharmaceutics14112403. Pharmaceutics. 2022. PMID: 36365221 Free PMC article.

2

Targeting multiple key signaling pathways in melanoma using leelamine.

Gowda R, Madhunapantula SV, Kuzu OF, Sharma A, Robertson GP. Gowda R, et al. Among authors: madhunapantula sv. Mol Cancer Ther. 2014 Jul;13(7):1679-89. doi: 10.1158/1535-7163.MCT-13-0867. Epub 2014 Mar 31. Mol Cancer Ther. 2014. PMID: 24688050 Free PMC article.

3

Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

Inamdar GS, Madhunapantula SV, Robertson GP. Inamdar GS, et al. Among authors: madhunapantula sv. Biochem Pharmacol. 2010 Sep 1;80(5):624-37. doi: 10.1016/j.bcp.2010.04.029. Epub 2010 May 9. Biochem Pharmacol. 2010. PMID: 20450891 Free PMC article. Review.

4

The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC.

Madhunapantula SV, Achur RN, Bhavanandan VP, Gowda DC. Madhunapantula SV, et al. Glycoconj J. 2007 Nov;24(8):465-73. doi: 10.1007/s10719-007-9039-y. Epub 2007 May 29. Glycoconj J. 2007. PMID: 17533514

5

Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan.

Madhunapantula SV, Achur RN, Gowda DC. Madhunapantula SV, et al. Infect Immun. 2007 Sep;75(9):4409-15. doi: 10.1128/IAI.00478-07. Epub 2007 Jun 25. Infect Immun. 2007. PMID: 17591790 Free PMC article.

6

Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.

Sharma A, Madhunapantula SV, Gowda R, Berg A, Neves RI, Robertson GP. Sharma A, et al. Among authors: madhunapantula sv. Am J Pathol. 2013 Apr;182(4):1151-62. doi: 10.1016/j.ajpath.2012.12.019. Epub 2013 Feb 12. Am J Pathol. 2013. PMID: 23416158 Free PMC article.

7

PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.

Madhunapantula SV, Desai D, Sharma A, Huh SJ, Amin S, Robertson GP. Madhunapantula SV, et al. Mol Cancer Ther. 2008 May;7(5):1297-308. doi: 10.1158/1535-7163.MCT-07-2267. Mol Cancer Ther. 2008. PMID: 18483317

8

Targeting sphingosine kinase-1 to inhibit melanoma.

Madhunapantula SV, Hengst J, Gowda R, Fox TE, Yun JK, Robertson GP. Madhunapantula SV, et al. Pigment Cell Melanoma Res. 2012 Mar;25(2):259-74. doi: 10.1111/j.1755-148X.2012.00970.x. Pigment Cell Melanoma Res. 2012. PMID: 22236408 Free PMC article.

9

The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.

Madhunapantula SV, Robertson GP. Madhunapantula SV, et al. Pigment Cell Melanoma Res. 2009 Aug;22(4):400-19. doi: 10.1111/j.1755-148X.2009.00585.x. Epub 2009 May 28. Pigment Cell Melanoma Res. 2009. PMID: 19493313 Free PMC article. Review.

10

Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.

Sharma AK, Sharma A, Desai D, Madhunapantula SV, Huh SJ, Robertson GP, Amin S. Sharma AK, et al. Among authors: madhunapantula sv. J Med Chem. 2008 Dec 25;51(24):7820-6. doi: 10.1021/jm800993r. J Med Chem. 2008. PMID: 19053750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page